BEIJING BEILU PHARMACEUTICAL
Beijing Beilu Pharmaceutical mainly engaged in the research and development, production, and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise. Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in the domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.
BEIJING BEILU PHARMACEUTICAL
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Euro PHP PHP 7 Pound Sterling Ubuntu Japanese Yen
Similar Organizations
Apeloa Pharmaceutical
Apeloa Pharmaceutical engaged in the research, development, production and sale of medicines.
Biokin Pharmaceutical
Biokin Pharmaceutical engages in the R&D, production and sales of pharmaceutical products.
Hunan Nucien Pharmaceutical
Hunan Nucien engages in the research and development, production, and sale of pharmaceutical product
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-06-01 | Geneseeq | Beijing Beilu Pharmaceutical investment in Series B - Geneseeq | 60 M CNY |
| 2014-08-01 | Geneseeq | Beijing Beilu Pharmaceutical investment in Series A - Geneseeq | 30 M CNY |